Seroprevalence against the measles virus after vaccination or natural infection in an adult population in Madinah, Saudi Arabia

References

• Smetana J, Chlibek R, Hanovcova I, Sosovickova R, Smetanova L, Gal P, Dite P. Decreasing seroprevalence of measles antibodies after vaccination - possible gap in measles protection in adults in the Czech Republic. PLoS One. 2017;12(1):e0170257. Epub 2017/ 01/14. doi:10.1371/journal.pone.0170257.
   PubMed Web of Science ®Google Scholar
• Moss WJ, Griffin DE. Measles. Lancet. 2012;379(9811):153–64. Epub 2011/ 08/23. doi:10.1016/S0140-6736(10)62352-5.
   PubMed Web of Science ®Google Scholar
• Coleman KP, Markey PG. Measles transmission in immunized and partially immunized air travellers. Epidemiol Infect. 2010;138(7):1012–15. Epub 2009/ 11/03. doi:10.1017/S0950268809991129.
   PubMed Web of Science ®Google Scholar
• The State of the World’s Children 1998: a UNICEF report. Malnutrition: causes, consequences, and solutions. Nutr Rev. 1998;56(4 Pt 1):115–23. Epub 1998/ 05/19. doi:10.1111/j.1753-4887.1998.tb01723.x.
   PubMed Web of Science ®Google Scholar
• Tufenkeji H, Kattan H. Childhood immunization in the Kingdom of Saudi Arabia. Ann Saudi Med. 1994;14(2):91–93. Epub 1994/ 03/01. doi:10.5144/0256-4947.1994.91.
   PubMed Web of Science ®Google Scholar
• Hegazy IS, Al-Beyari TH, Al-Amri AH, Noeman SA, Qureshi NA, Abdelgadir MH. A seroepidemiological study of measles: some practical implications for measles immunization program, Kingdom of Saudi Arabia. Ann Saudi Med. 1994;14(5):399–404. Epub 1994/ 09/01. doi:10.5144/0256-4947.1994.399.
   PubMed Web of Science ®Google Scholar
• Stein CE, Birmingham M, Kurian M, Duclos P, Strebel P. The global burden of measles in the year 2000–a model that uses country-specific indicators. J Infect Dis. 2003;187(Suppl 1):S8–14. Epub 2003/ 05/02. doi:10.1086/368114.
   PubMedGoogle Scholar
• Patel MK, Dumolard L, Nedelec Y, Sodha SV, Steulet C, Gacic-Dobo M, Kretsinger K, McFarland J, Rota PA, Goodson JL, et al. Progress toward regional measles elimination - worldwide, 2000-2018. MMWR Morb Mortal Wkly Rep. 2019;68(48):1105–11. Epub 2019/ 12/06. doi:10.15585/mmwr.mm6848a1.
   PubMed Web of Science ®Google Scholar
• van den Hof S, Conyn-van Spaendonck MA, van Steenbergen JE. Measles epidemic in the Netherlands, 1999-2000. J Infect Dis. 2002;186(10):1483–86. Epub 2002/ 10/31. doi:10.1086/344894.
   PubMed Web of Science ®Google Scholar
• Al-Arabi Al-Ghamdi AM, Al-Faraj MH, Ibrahim HM, Al Mamun M. Epidemiological analysis of notified measles cases and review of surveillance system during an outbreak in Tabuk, Saudi Arabia. Ann Epidemiol. 2011;21(4):262–71. Epub 2011/ 03/08. doi:10.1016/j.annepidem.2010.12.004.
   PubMed Web of Science ®Google Scholar
• Jahan S, Al Saigul AM, Abu Baker MA, Alataya AO, Hamed SA. Measles outbreak in Qassim, Saudi Arabia 2007: epidemiology and evaluation of outbreak response. J Public Health (Oxf). 2008;30(4):384–90. Epub 2008/ 08/22. doi:10.1093/pubmed/fdn070.
   PubMed Web of Science ®Google Scholar
• Al-Abdullah N. A measles outbreak in a refugee community in Jeddah City, Saudi Arabia. J Hosp Infect. 2018;100(4):e264–e5. Epub 2018/ 06/03. doi:10.1016/j.jhin.2018.05.018.
   PubMed Web of Science ®Google Scholar
• Khalil MK, Nadrah HM, Al Yahia OA, ElGhazali G. Seroresponse to the second measles vaccine dose at school entry in Qassim province, Saudi Arabia. East Mediterr Health J. 2011;17(3):191–95. Epub 2011/ 07/09. doi:10.26719/2011.17.3.191.
   PubMedGoogle Scholar
• Khalil MK, Al-Mazrou YY, Al-Jeffri M, Al-Ghamdy YS. Measles immunization in Saudi Arabia: the need for change. East Mediterr Health J. 2001;7(4–5):829–34. Epub 2004/ 08/31.
   PubMedGoogle Scholar
• Poi KM. Measles: the epidemiology and control of an outbreak. J Am Coll Health. 1983;31(4):158–61. Epub 1983/ 02/01. doi:10.1080/07448481.1983.9940433.
   PubMedGoogle Scholar
• Khalil MK, Al-Mazrou YY, AlHowasi MN, Al-Jeffri M. Measles in Saudi Arabia: from control to elimination. Ann Saudi Med. 2005;25(4):324–28. Epub 2005/ 10/11. doi:10.5144/0256-4947.2005.324.
   PubMed Web of Science ®Google Scholar
• Greenwood B. The contribution of vaccination to global health: past, present and future. Philosophical Transactions of the Royal Society B: Biological Sciences. 2014;369(1645):20130433. doi:10.1098/rstb.2013.0433.
   PubMed Web of Science ®Google Scholar
• Poethko-Müller C, Mankertz A. Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity. PLoS One. 2012;7(8):e42867. Epub 2012/ 08/11. doi:10.1371/journal.pone.0042867.
   PubMed Web of Science ®Google Scholar
• Kang HJ, Han YW, Kim SJ, Kim YJ, Kim AR, Kim JA, et al. An increasing, potentially measles-susceptible population over time after vaccination in Korea. Vaccine. 2017;35(33):4126–32
   PubMed Web of Science ®Google Scholar
• Hanna-Wakim R, Yasukawa LL, Sung P, Arvin AM, Gans HA. Immune responses to mumps vaccine in adults who were vaccinated in childhood. J Infect Dis. 2008;197(12):1669–75. Epub 2008/ 04/19. doi:10.1086/588195.
   PubMed Web of Science ®Google Scholar
• Briss PA, Fehrs LJ, Parker RA, Wright PF, Sannella EC, Hutcheson RH, Schaffner W. Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity. J Infect Dis. 1994;169(1):77–82. Epub 1994/ 01/01. doi:10.1093/infdis/169.1.77.
   PubMed Web of Science ®Google Scholar
• Held L, Hens N, O’Neill P, & Wallinga J, editors. Handbook of Infectious Disease Data Analysis. 1st ed. CRC Press; 2019. doi:10.1201/9781315222912.
   Google Scholar
• Haralambieva IH, Ovsyannikova IG, O’Byrne M, Pankratz VS, Jacobson RM, Poland GA. A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccine. Vaccine. 2011;29(27):4485–91. Epub 2011/ 05/05. doi:10.1016/j.vaccine.2011.04.037.
   PubMed Web of Science ®Google Scholar
• Al-Mazrou YY, al-Jeffri M, Ahmed OM, Aziz KM, Mishkas AH. Measles immunization: early two-doses policy experience. J Trop Pediatr. 1999;45(2):98–104. Epub 1999/ 05/26. doi:10.1093/tropej/45.2.98.
   PubMed Web of Science ®Google Scholar
• Xiong Y, Wang D, Lin W, Tang H, Chen S, Ni J. Age-related changes in serological susceptibility patterns to measles: results from a seroepidemiological study in Dongguan, China. Hum Vaccine Immunother. 2014;10(4):1097–03. Epub 2014/ 01/23. doi:10.4161/hv.27734.
   PubMed Web of Science ®Google Scholar
• Coppeta L, Pietroiusti A, Lieto P, Ferraro M, Grelli S, Stillo M, Magrini A. Measles immunity in an Italian teaching hospital. Occup Med (Chic Ill). 2018;69(2):143–45. doi:10.1093/occmed/kqy132.
   Web of Science ®Google Scholar
• Chen CJ, Lee PI, Hsieh YC, Chen PY, Ho YH, Chang CJ, Liu D-P, Chang F-Y, Chiu C-H, Huang Y-C, et al. Waning population immunity to measles in Taiwan. Vaccine. 2012;30(47):6721–27. Epub 2012/ 05/29. doi:10.1016/j.vaccine.2012.05.019.
   PubMed Web of Science ®Google Scholar
• de Melker H, Pebody RG, Edmunds WJ, Levy-Bruhl D, Valle M, Rota MC, SALMASO S, van den HOF S, BERBERS G, SALIOU P, et al. The seroepidemiology of measles in Western Europe. Epidemiol Infect. 2001;126(2):249–59. Epub 2001/ 05/15. doi:10.1017/S0950268801005234.
   PubMed Web of Science ®Google Scholar
• Rearigh L, O’Neill J, Kubat M, Sayles H, Swindells S, Bares SH. Surprisingly low levels of measles immunity in persons with HIV: a seroprevalence survey in a United States HIV clinic. Open Forum Infect Dis. 2020;7(10):ofaa428. Epub 2020/ 10/20. doi:10.1093/ofid/ofaa428.
   PubMed Web of Science ®Google Scholar
• Trentini F, Poletti P, Melegaro A, Merler S. The introduction of ‘No jab, No school’ policy and the refinement of measles immunisation strategies in high-income countries. BMC Med. 2019;17(1):86. Epub 2019/ 05/18. doi:10.1186/s12916-019-1318-5.
   PubMed Web of Science ®Google Scholar